APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lornoxicam Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lornoxicam Tablets Market Outlook and Growth Opportunities 2026

Report ID 174009030429 December 2025198 pages

Choose your research edition.

Industry ResearchLornoxicam Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Lornoxicam Tablets Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Lornoxicam Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lornoxicam Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Lornoxicam Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Lornoxicam Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lornoxicam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lornoxicam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lornoxicam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lornoxicam Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lornoxicam Tablets market include Glenmark, Lupin Limited, Takeda Pharmaceuticals, Shandong Jincheng Pharmaceutical and Zhejiang Zhenyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lornoxicam Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lornoxicam Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lornoxicam Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lornoxicam Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Lornoxicam Tablets Segment by Company

Glenmark

Lupin Limited

Takeda Pharmaceuticals

Shandong Jincheng Pharmaceutical

Zhejiang Zhenyuan Pharmaceutical

Lornoxicam Tablets Segment by Type

4mg

8mg

Lornoxicam Tablets Segment by Application

Hospital and Clinic

Pharmacy

Lornoxicam Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lornoxicam Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lornoxicam Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lornoxicam Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Lornoxicam Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lornoxicam Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lornoxicam Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lornoxicam Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lornoxicam Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lornoxicam Tablets industry.

Chapter 3: Detailed analysis of Lornoxicam Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lornoxicam Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lornoxicam Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lornoxicam Tablets Industry Trends Table 2. Lornoxicam Tablets Industry Drivers Table 3. Lornoxicam Tablets Industry Opportunities and Challenges Table 4. Lornoxicam Tablets Industry Restraints Table 5. Global Lornoxicam Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lornoxicam Tablets Revenue Share by Company (2021-2026) Table 7. Global Lornoxicam Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lornoxicam Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Lornoxicam Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lornoxicam Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lornoxicam Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Lornoxicam Tablets Company, Product Type & Application Table 13. Global Lornoxicam Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lornoxicam Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 4mg Table 18. Significant Companies of 8mg Table 19. Global Lornoxicam Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lornoxicam Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Lornoxicam Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Lornoxicam Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Lornoxicam Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Lornoxicam Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lornoxicam Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lornoxicam Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lornoxicam Tablets Sales Value Share by Type (2021-2026) Table 28. Global Lornoxicam Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Global Lornoxicam Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Lornoxicam Tablets Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Lornoxicam Tablets Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Lornoxicam Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Lornoxicam Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Lornoxicam Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Lornoxicam Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Lornoxicam Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Lornoxicam Tablets Sales Value Share by Application (2021-2026) Table 40. Global Lornoxicam Tablets Sales Value Share by Application (2027-2032) Table 41. Global Lornoxicam Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lornoxicam Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Lornoxicam Tablets Sales Market Share by Region (2021-2026) Table 44. Global Lornoxicam Tablets Sales by Region (2027-2032) & (K Units) Table 45. Global Lornoxicam Tablets Sales Market Share by Region (2027-2032) Table 46. Global Lornoxicam Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Lornoxicam Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Lornoxicam Tablets Sales Value Share by Region (2021-2026) Table 49. Global Lornoxicam Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Lornoxicam Tablets Sales Value Share by Region (2027-2032) Table 51. Global Lornoxicam Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Lornoxicam Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Lornoxicam Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Lornoxicam Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Lornoxicam Tablets Sales by Country (2021-2026) & (K Units) Table 56. Global Lornoxicam Tablets Sales Market Share by Country (2021-2026) Table 57. Global Lornoxicam Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Lornoxicam Tablets Sales Market Share by Country (2027-2032) Table 59. Global Lornoxicam Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Lornoxicam Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Lornoxicam Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Lornoxicam Tablets Sales Value Market Share by Country (2027-2032) Table 63. Glenmark Company Information Table 64. Glenmark Business Overview Table 65. Glenmark Lornoxicam Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Glenmark Lornoxicam Tablets Product Portfolio Table 67. Glenmark Recent Development Table 68. Lupin Limited Company Information Table 69. Lupin Limited Business Overview Table 70. Lupin Limited Lornoxicam Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Lupin Limited Lornoxicam Tablets Product Portfolio Table 72. Lupin Limited Recent Development Table 73. Takeda Pharmaceuticals Company Information Table 74. Takeda Pharmaceuticals Business Overview Table 75. Takeda Pharmaceuticals Lornoxicam Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceuticals Lornoxicam Tablets Product Portfolio Table 77. Takeda Pharmaceuticals Recent Development Table 78. Shandong Jincheng Pharmaceutical Company Information Table 79. Shandong Jincheng Pharmaceutical Business Overview Table 80. Shandong Jincheng Pharmaceutical Lornoxicam Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shandong Jincheng Pharmaceutical Lornoxicam Tablets Product Portfolio Table 82. Shandong Jincheng Pharmaceutical Recent Development Table 83. Zhejiang Zhenyuan Pharmaceutical Company Information Table 84. Zhejiang Zhenyuan Pharmaceutical Business Overview Table 85. Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Product Portfolio Table 87. Zhejiang Zhenyuan Pharmaceutical Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Lornoxicam Tablets Distributors List Table 91. Lornoxicam Tablets Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Lornoxicam Tablets Product Image Figure 2. Global Lornoxicam Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lornoxicam Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lornoxicam Tablets Sales (2021-2032) & (K Units) Figure 5. Global Lornoxicam Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lornoxicam Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 4mg Image Figure 10. 8mg Image Figure 11. Global Lornoxicam Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lornoxicam Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lornoxicam Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Lornoxicam Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lornoxicam Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lornoxicam Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Global Lornoxicam Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Lornoxicam Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Lornoxicam Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Lornoxicam Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Lornoxicam Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Lornoxicam Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Lornoxicam Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Lornoxicam Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Lornoxicam Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Lornoxicam Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Lornoxicam Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Lornoxicam Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Lornoxicam Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Lornoxicam Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Lornoxicam Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Lornoxicam Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Lornoxicam Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Lornoxicam Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Lornoxicam Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Lornoxicam Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Lornoxicam Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Lornoxicam Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Lornoxicam Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 4mg
  • 8mg
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • Glenmark
  • Lupin Limited
  • Takeda Pharmaceuticals
  • Shandong Jincheng Pharmaceutical
  • Zhejiang Zhenyuan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lornoxicam Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Lornoxicam Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Lornoxicam Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lornoxicam Tablets Market Dynamics
  1. 2.1 Lornoxicam Tablets Industry Trends
  2. 2.2 Lornoxicam Tablets Industry Drivers
  3. 2.3 Lornoxicam Tablets Industry Opportunities and Challenges
  4. 2.4 Lornoxicam Tablets Industry Restraints
3 Lornoxicam Tablets Market by Company
  1. 3.1 Global Lornoxicam Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Lornoxicam Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Lornoxicam Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Lornoxicam Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Lornoxicam Tablets Company Ranking (2024-2026)
  6. 3.6 Global Lornoxicam Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Lornoxicam Tablets Company Product Type and Application
  8. 3.8 Global Lornoxicam Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lornoxicam Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lornoxicam Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lornoxicam Tablets Market by Type
  1. 4.1 Lornoxicam Tablets Type Introduction
  2. 4.1.1 4mg
  3. 4.1.2 8mg
  4. 4.2 Global Lornoxicam Tablets Sales Volume by Type
  5. 4.2.1 Global Lornoxicam Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lornoxicam Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lornoxicam Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lornoxicam Tablets Sales Value by Type
  9. 4.3.1 Global Lornoxicam Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lornoxicam Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lornoxicam Tablets Sales Value Share by Type (2021-2032)
5 Lornoxicam Tablets Market by Application
  1. 5.1 Lornoxicam Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.2 Global Lornoxicam Tablets Sales Volume by Application
  5. 5.2.1 Global Lornoxicam Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lornoxicam Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Lornoxicam Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Lornoxicam Tablets Sales Value by Application
  9. 5.3.1 Global Lornoxicam Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Lornoxicam Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Lornoxicam Tablets Sales Value Share by Application (2021-2032)
6 Lornoxicam Tablets Regional Sales and Value Analysis
  1. 6.1 Global Lornoxicam Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lornoxicam Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Lornoxicam Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Lornoxicam Tablets Sales by Region (2027-2032)
  5. 6.3 Global Lornoxicam Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lornoxicam Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lornoxicam Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lornoxicam Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Lornoxicam Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lornoxicam Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Lornoxicam Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lornoxicam Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Lornoxicam Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lornoxicam Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lornoxicam Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lornoxicam Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Lornoxicam Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lornoxicam Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lornoxicam Tablets Sales Value Share by Country, 2025 VS 2032
7 Lornoxicam Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Lornoxicam Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lornoxicam Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lornoxicam Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Lornoxicam Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Lornoxicam Tablets Sales by Country (2027-2032)
  6. 7.4 Global Lornoxicam Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lornoxicam Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lornoxicam Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lornoxicam Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lornoxicam Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lornoxicam Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Glenmark
  2. 8.1.1 Glenmark Company Information
  3. 8.1.2 Glenmark Business Overview
  4. 8.1.3 Glenmark Lornoxicam Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Glenmark Lornoxicam Tablets Product Portfolio
  6. 8.1.5 Glenmark Recent Developments
  7. 8.2 Lupin Limited
  8. 8.2.1 Lupin Limited Company Information
  9. 8.2.2 Lupin Limited Business Overview
  10. 8.2.3 Lupin Limited Lornoxicam Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lupin Limited Lornoxicam Tablets Product Portfolio
  12. 8.2.5 Lupin Limited Recent Developments
  13. 8.3 Takeda Pharmaceuticals
  14. 8.3.1 Takeda Pharmaceuticals Company Information
  15. 8.3.2 Takeda Pharmaceuticals Business Overview
  16. 8.3.3 Takeda Pharmaceuticals Lornoxicam Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Pharmaceuticals Lornoxicam Tablets Product Portfolio
  18. 8.3.5 Takeda Pharmaceuticals Recent Developments
  19. 8.4 Shandong Jincheng Pharmaceutical
  20. 8.4.1 Shandong Jincheng Pharmaceutical Company Information
  21. 8.4.2 Shandong Jincheng Pharmaceutical Business Overview
  22. 8.4.3 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Product Portfolio
  24. 8.4.5 Shandong Jincheng Pharmaceutical Recent Developments
  25. 8.5 Zhejiang Zhenyuan Pharmaceutical
  26. 8.5.1 Zhejiang Zhenyuan Pharmaceutical Company Information
  27. 8.5.2 Zhejiang Zhenyuan Pharmaceutical Business Overview
  28. 8.5.3 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Product Portfolio
  30. 8.5.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lornoxicam Tablets Value Chain Analysis
  2. 9.1.1 Lornoxicam Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lornoxicam Tablets Sales Mode & Process
  6. 9.2 Lornoxicam Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lornoxicam Tablets Distributors
  9. 9.2.3 Lornoxicam Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst